Friday, February 16, 2018 9:10:26 AM
Athersys Poised For Lucrative Stem Cell Stroke Partnership This Year
May 16, 2017 6:23 AM ET|112 comments| About: Athersys, Inc. (ATHX), Includes: RTIX
This article is now exclusive for PRO subscribers.
Wall Street Titan
Wall Street Titan
Regenerative Medicine, small-cap, alternative energy
MARKETPLACEStem Cell News and Analysis
Get email alerts
Summary
Fast Track and Special Protocol Assessment designations sets stage for global stroke partnership in 2017.
$1,000,000 milestone payment indicates that Athersys's proprietary MAPCs are performing in real-world clinical application.
Mystery surrounding Japan stroke patient enrollment delay resolved.
Over the last few months, several SA followers have requested an update on stem cell biotech, Athersys Inc. (NASDAQ:ATHX). Realistically, there really hadn't been any significant developments worthy of an update over the......
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM